How the obesity drug market is evolving in unexpected ways as we enter 2025
Daily oral tablets are expected to enter the market in 2026 along with medications which have fewer side effects while food companies look to get involved
We use cookies to ensure that we give you the best experience on our website.
If you continue without changing your settings, we'll assume that you are happy to receive all cookies from this website.
You may change your preferences at any time.
